Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Global Arthritis Research Network (GARN): 4th World Congress on Arthritis in Montreal

Oral presentation

Rheumatoid arthritis: a heterogeneous disease evaluated by DNA-microarray technology

PV Kasperkovitz1, T Timmer1, T Smeets2, PP Tak2, TWJ Huizinga3, GS Firestein4, F Rustenburg1, TCTM van der Pouw Kraan1, M Fero5 and CL Verweij1

Author Affiliations

1 Department of Molecular Cell Biology and Immunology, VUMC, Amsterdam, The Netherlands

2 Department of Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam, The Netherlands

3 Department of Rheumatology, LUMC, Leiden, The Netherlands

4 Division of Rheumatology, Allergy and Immunology, UCSD, La Jolla, California, USA

5 Stanford Functional Genomics, Stanford University, California, USA

For all author emails, please log on.

Arthritis Res Ther 2004, 6(Suppl 3):5  doi:10.1186/ar1339

The electronic version of this article is the complete one and can be found online at:


Published:13 September 2004

©

Oral presentation

The molecular pathogenesis of rheumatoid arthritis (RA) is still poorly understood and its clinical course can vary widely. We apply a systems biology approach to gain insight into the complex pathogenesis and disease heterogeneity. Genomics studies revealed considerable heterogeneity in global gene expression signatures between synovial tissue specimens from different patients with RA. Based on the molecular signatures, at least two distinct subsets of RA tissues could be identified. One class revealed abundant expression of gene clusters indicative of an ongoing activation of the adaptive immune response, whereas the other class resembled the expression pattern of osteoarthritic tissues, which are characterized by a low inflammatory gene expression signature and increased tissue remodeling. The molecular heterogeneity is featured not only at the whole synovial tissue level, but also at the level of fibroblast-like synoviocytes (FLS) cultured from those tissues. One of the most impressive features of our gene expression profiling studies is the clear correlation of the FLS phenotype with that of paired synovial tissue from which the cells were derived. One class of FLS is tightly related to the presence of lymphocytes in the lesions, whereas the other class of FLS suggests that synoviocyte-mediated invasion appears to be less dependent on infiltrating immune cells. These data support the notion that heterogeneity observed between synovial tissues is reflected in the FLS as a stable trait. Clearly, the list of genes that are differentially expressed between the tissue and FLS subgroups facilitates our understanding of the pathophysiology of the molecular forms of disease. Moreover, the differences in the gene expression profiles reflect important aspects of biological variation within the clinically diagnosed disease that provide a molecular basis for the well recognized but as yet poorly understood heterogeneity in RA and may help to (sub)classify rheumatic diseases.

Acknowledgements

The authors are grateful to Dr Pat Brown and Dr David Botstein, in whose laboratories part of the work described in this report was performed. Supported in part by the Howard Hughes Medical Institute, a grant from the National Cancer Institute, a grant from the Netherlands Organization for Scientific Research, and the Dutch Arthritis Foundation.